dextroamphetamine
Megjelenés
| Clinical data | |||
|---|---|---|---|
| Pronunciation | /ˌdɛkstroʊæmˈfɛtəmiːn/ | ||
| Trade names | Dexedrine, others | ||
| Other names | d-Amphetamine, (S)-Amphetamine, S(+)-Amphetamine | ||
| AHFS/Drugs.com | Monograph | ||
| MedlinePlus | a605027 | ||
| License data | |||
| Pregnancy category |
| ||
| Dependence liability | Physical: None Psychological: Moderate | ||
| Addiction liability | Moderate – high | ||
| Routes of administration | By mouth, transdermal, intravenous, insufflation, rectal | ||
| Drug class | Stimulant | ||
| ATC code | |||
| Legal status | |||
| Legal status |
| ||
| Pharmacokinetic data | |||
| Bioavailability | Oral: ~90% | ||
| Protein binding | 15–40% | ||
| Metabolism | CYP2D6, DBH, FMO3 | ||
| Onset of action | IR dosing: 0.5–1.5 hours XR dosing: 1.5–2 hours | ||
| Elimination half-life | 9–11 hours pH-dependent: 7–34 hours | ||
| Duration of action | IR dosing: 3–6 hours XR dosing: 8–12 hours | ||
| Excretion | Kidney (45%); urinary pH-dependent | ||
| Identifiers | |||
| |||
| CAS Number | |||
| PubChem CID | |||
| IUPHAR/BPS | |||
| DrugBank | |||
| ChemSpider | |||
| UNII | |||
| KEGG | |||
| ChEBI | |||
| ChEMBL | |||
| Chemical and physical data | |||
| Formula | C9H13N | ||
| Molar mass | 135.21 g·mol−1 | ||
| 3D model (JSmol) | |||
| Chirality | Dextrorotatory enantiomer | ||
| Density | 0.913 g/cm3 | ||
| Boiling point | 201.5 °C (394.7 °F) | ||
| Solubility in water | 20mg per ml | ||
| |||
| |||
| | |||
Főnév
dextroamphetamine (tsz. dextroamphetamines)
- dextroamphetamine - Szótár.net (en-hu)
- dextroamphetamine - Sztaki (en-hu)
- dextroamphetamine - Merriam–Webster
- dextroamphetamine - Cambridge
- dextroamphetamine - WordNet
- dextroamphetamine - Яндекс (en-ru)
- dextroamphetamine - Google (en-hu)
- dextroamphetamine - Wikidata
- dextroamphetamine - Wikipédia (angol)